跳至主要内容
临床试验/CTRI/2025/09/095169
CTRI/2025/09/095169尚未招募2 期

A Randomized Clinical study of Nasya with Gandharyadi Ghrita in the Management of Ardhavabhedaka wsrt Migraine

Dr Prajakta korde2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年10月1日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
100
试验地点
2
主要终点
1.Reduction in frequency of migraine (Ardhavabhedak) attacks: Measured as the number of episodes per month before and after intervention.

研究概览

简要总结

Migraine of volunteers will be assessed by using MIDAS scale.

Volunteers with moderate and severe migraine levels will be suggested for Nasya karma**with Shadbindu Taila in group A (50 Patients) and Nasya karma with Gandharyadi Ghrita ingroup B (50 Patients ) for alternate days  for 14 days

Assessment will be done by using MIDAS scale after the completion of Nasya Karma to check the

sustainability of Nasya Karma will be taken by using MIDAS scale on interval of 1st 15th 30th 60th 90th 120th day

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
25.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Patients with a history of at least five migraine episodes, but not currently experiencing an active episode, were enrolled in this clinical trial.
  • Moderate to Severe Migraine Patients.
  • Age Group: 25 Yrs.
  • Sex : Male And Female Both 5) The Volunteers Who Duly Signed the Concern Form Will Be Considered.
  • Yogya for Nasya Karma.(as per classical indications).
  • Ability to follow the treatment schedule and attend follow-up visits.

排除标准

  • Structural brain pathology,incranial lesion or history of head trauma.
  • Action episode of Migraine.
  • Non vascular and psychiatric disorder.
  • severe systemic illness like uncontrolled diabetes, hypertension, epilepsy.
  • H/O or K/C/O bleeding disorder.
  • known allergy to ingredients of Gandharvyadi ghrit or shadbindu taila.

结局指标

主要结局

1.Reduction in frequency of migraine (Ardhavabhedak) attacks: Measured as the number of episodes per month before and after intervention.

时间窗: Sustainability of nasya karma will be taken by using Midas scale interval of 1st 15th 30th 60th 90th 120th day

2. Reduction in intensity of headache: Assessed using the MIDAS Scale.

时间窗: Sustainability of nasya karma will be taken by using Midas scale interval of 1st 15th 30th 60th 90th 120th day

次要结局

  • 1. Reduction in duration of migraine episodes: Measured in hours per episode before and(after treatment.)

研究者

发起方
Dr Prajakta korde
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Prajakta korde

Bharati Vidyapeeth (Deemed to be University) College and Hospital of Ayurveda Pune 43

研究点 (2)

Loading locations...

相似试验

Study to see the effect of Gandharyadi Ghrita in the... | 临床试验